Anti-IL-6 receptor antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-IL-6 receptor antibodies, covering 2025-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy [Phase 2]